Download Files:
Broxyquinoline
$60 – $66
Products Details
Product Description
– Broxyquinoline (Dibromohydroxyquinoline) is a potent severe fever with thrombocytopenia syndrome virus (SFTSV) inhibitor with an IC50 of 5.8 µM. Broxyquinoline is an antiprotozoal agent[1][2].
Web ID
– HY-B1212
Storage Temperature
– 4°C (Powder, protect from light)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C9H5Br2NO
References
– [1]Fritzler JM, et al. Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP). J Antimicrob Chemother. 2012 Mar;67(3):609-17.|[2]Shuofeng Yuan, et al. Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome Virus. Viruses. 2019 Apr 25;11(4):385.
CAS Number
– 521-74-4
Molecular Weight
– 302.95
Compound Purity
– 99.93
SMILES
– OC1=C2N=CC=CC2=C(Br)C=C1Br
Clinical Information
– Launched
Research Area
– Infection
Solubility
– DMSO : 31.25 mg/mL (ultrasonic)|H2O : 0.67 mg/mL (ultrasonic)
Target
– Parasite
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
